y passion has long been helping businesses succeed in today’s landscape. I serve on a variety of boards to help apply my research to the work these organizations are setting out to do.
A privately owned, Swiss-based startup focused on specialty catalysts, 2011-2018.
A privately owned, Cambridge-based biotechnology company developing therapeutics to address metabolic dysregulation, 2011-present.
A publicly traded biotechnology company developing drugs for neurological diseases. Served on audit and governance committees, 2016-2017.
A publicly traded manufacturing services company serving the pharmaceutical industry. Served on audit committee, 2015-2017.
A privately held UK based biotechnology company developing cell therapies, 2018 to present.